nodes	percent_of_prediction	percent_of_DWPC	metapath
Tazarotene—RARG—Nuclear Receptors—NR4A2—Parkinson's disease	0.044	0.0556	CbGpPWpGaD
Tazarotene—RARG—tongue—Parkinson's disease	0.0403	0.193	CbGeAlD
Tazarotene—RARB—Nuclear Receptors—NR4A2—Parkinson's disease	0.0394	0.0498	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptors—NR4A2—Parkinson's disease	0.0378	0.0478	CbGpPWpGaD
Tazarotene—RXRB—Nuclear Receptors—NR4A2—Parkinson's disease	0.0378	0.0478	CbGpPWpGaD
Tazarotene—RARG—Nuclear Receptor transcription pathway—NR4A2—Parkinson's disease	0.0347	0.0439	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptor transcription pathway—NR4A2—Parkinson's disease	0.0312	0.0394	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptor transcription pathway—NR4A2—Parkinson's disease	0.0299	0.0378	CbGpPWpGaD
Tazarotene—RXRB—Nuclear Receptor transcription pathway—NR4A2—Parkinson's disease	0.0299	0.0378	CbGpPWpGaD
Tazarotene—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.0202	0.0255	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.0181	0.0229	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.0174	0.0219	CbGpPWpGaD
Tazarotene—RARG—Vitamin A and Carotenoid Metabolism—CYP2E1—Parkinson's disease	0.0167	0.0211	CbGpPWpGaD
Tazarotene—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.0158	0.0199	CbGpPWpGaD
Tazarotene—RARB—Vitamin A and Carotenoid Metabolism—CYP2E1—Parkinson's disease	0.015	0.019	CbGpPWpGaD
Tazarotene—RXRB—Vitamin A and Carotenoid Metabolism—CYP2E1—Parkinson's disease	0.0144	0.0182	CbGpPWpGaD
Tazarotene—RARA—Vitamin A and Carotenoid Metabolism—CYP2E1—Parkinson's disease	0.0144	0.0182	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.0141	0.0179	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.0135	0.0171	CbGpPWpGaD
Tazarotene—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—Parkinson's disease	0.0121	0.0153	CbGpPWpGaD
Tazarotene—RARB—head—Parkinson's disease	0.012	0.0575	CbGeAlD
Tazarotene—CYP2C8—CYP2E1 reactions—CYP2D6—Parkinson's disease	0.0112	0.0141	CbGpPWpGaD
Tazarotene—RXRB—head—Parkinson's disease	0.011	0.0528	CbGeAlD
Tazarotene—RARB—cerebellum—Parkinson's disease	0.0107	0.0513	CbGeAlD
Tazarotene—RXRB—nervous system—Parkinson's disease	0.0104	0.0501	CbGeAlD
Tazarotene—CYP2C8—CYP2E1 reactions—CYP2E1—Parkinson's disease	0.0102	0.0129	CbGpPWpGaD
Tazarotene—RXRB—central nervous system—Parkinson's disease	0.0101	0.0482	CbGeAlD
Tazarotene—RXRB—cerebellum—Parkinson's disease	0.00983	0.0471	CbGeAlD
Tazarotene—RARG—head—Parkinson's disease	0.00978	0.0469	CbGeAlD
Tazarotene—RARG—nervous system—Parkinson's disease	0.00928	0.0444	CbGeAlD
Tazarotene—RARA—head—Parkinson's disease	0.0092	0.0441	CbGeAlD
Tazarotene—RARG—central nervous system—Parkinson's disease	0.00893	0.0428	CbGeAlD
Tazarotene—RARG—cerebellum—Parkinson's disease	0.00873	0.0418	CbGeAlD
Tazarotene—RARA—nervous system—Parkinson's disease	0.00872	0.0418	CbGeAlD
Tazarotene—RARB—brain—Parkinson's disease	0.00869	0.0416	CbGeAlD
Tazarotene—RARA—central nervous system—Parkinson's disease	0.0084	0.0402	CbGeAlD
Tazarotene—RARA—cerebellum—Parkinson's disease	0.00821	0.0393	CbGeAlD
Tazarotene—RARG—Retinoic acid receptors-mediated signaling—MAPK8—Parkinson's disease	0.00813	0.0103	CbGpPWpGaD
Tazarotene—RXRB—brain—Parkinson's disease	0.00799	0.0383	CbGeAlD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—MAP3K5—Parkinson's disease	0.00732	0.00925	CbGpPWpGaD
Tazarotene—RARB—Retinoic acid receptors-mediated signaling—MAPK8—Parkinson's disease	0.00729	0.00922	CbGpPWpGaD
Tazarotene—RARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—Parkinson's disease	0.00721	0.00912	CbGpPWpGaD
Tazarotene—RARG—brain—Parkinson's disease	0.00709	0.034	CbGeAlD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—MAP3K5—Parkinson's disease	0.00702	0.00887	CbGpPWpGaD
Tazarotene—RXRB—Retinoic acid receptors-mediated signaling—MAPK8—Parkinson's disease	0.00699	0.00884	CbGpPWpGaD
Tazarotene—RARA—Retinoic acid receptors-mediated signaling—MAPK8—Parkinson's disease	0.00699	0.00884	CbGpPWpGaD
Tazarotene—CYP2C8—Xenobiotics—CYP2D6—Parkinson's disease	0.00693	0.00876	CbGpPWpGaD
Tazarotene—CYP2C8—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.00667	0.00843	CbGpPWpGaD
Tazarotene—RARA—brain—Parkinson's disease	0.00667	0.0319	CbGeAlD
Tazarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—TNF—Parkinson's disease	0.00647	0.00818	CbGpPWpGaD
Tazarotene—CYP2C8—Xenobiotics—CYP2E1—Parkinson's disease	0.00634	0.00802	CbGpPWpGaD
Tazarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—Parkinson's disease	0.0062	0.00784	CbGpPWpGaD
Tazarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—Parkinson's disease	0.0062	0.00784	CbGpPWpGaD
Tazarotene—CYP2C8—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.0061	0.00771	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—MAPT—Parkinson's disease	0.00607	0.00768	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—NR4A2—Parkinson's disease	0.006	0.00758	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—MAPT—Parkinson's disease	0.00582	0.00736	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—NR4A2—Parkinson's disease	0.00538	0.0068	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—NR4A2—Parkinson's disease	0.00516	0.00652	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—NR4A2—Parkinson's disease	0.00516	0.00652	CbGpPWpGaD
Tazarotene—RXRB—Regulation of Androgen receptor activity—MAPK8—Parkinson's disease	0.00443	0.0056	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—PRKRA—Parkinson's disease	0.0041	0.00518	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—PRKRA—Parkinson's disease	0.00368	0.00465	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	0.00367	0.00464	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	0.00361	0.00456	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—ABCB1—Parkinson's disease	0.00355	0.00449	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—PRKRA—Parkinson's disease	0.00353	0.00446	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—PRKRA—Parkinson's disease	0.00353	0.00446	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	0.00352	0.00444	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	0.00346	0.00438	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—ABCB1—Parkinson's disease	0.00341	0.0043	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	0.00321	0.00405	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—INS—Parkinson's disease	0.00316	0.004	CbGpPWpGaD
Tazarotene—CYP2C8—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.00314	0.00397	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	0.00307	0.00388	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—TAF1—Parkinson's disease	0.00289	0.00365	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—NR4A2—Parkinson's disease	0.00289	0.00365	CbGpPWpGaD
Tazarotene—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.00288	0.00364	CbGpPWpGaD
Tazarotene—CYP2C8—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.00284	0.00359	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—CTGF—Parkinson's disease	0.0027	0.00342	CbGpPWpGaD
Tazarotene—CYP2C8—brain—Parkinson's disease	0.00264	0.0127	CbGeAlD
Tazarotene—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.00263	0.00333	CbGpPWpGaD
Tazarotene—CYP2C8—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.0026	0.00328	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—TAF1—Parkinson's disease	0.00259	0.00327	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—NR4A2—Parkinson's disease	0.00259	0.00327	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—TAF1—Parkinson's disease	0.00248	0.00314	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—NR4A2—Parkinson's disease	0.00248	0.00314	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—TAF1—Parkinson's disease	0.00248	0.00314	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—NR4A2—Parkinson's disease	0.00248	0.00314	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—CTGF—Parkinson's disease	0.00243	0.00307	CbGpPWpGaD
Tazarotene—CYP2C8—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.00233	0.00295	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—CTGF—Parkinson's disease	0.00233	0.00294	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—CTGF—Parkinson's disease	0.00233	0.00294	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—RPL6—Parkinson's disease	0.00231	0.00292	CbGpPWpGaD
Tazarotene—CYP2C8—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.00221	0.00279	CbGpPWpGaD
Tazarotene—CYP2C8—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00213	0.0027	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—RPL6—Parkinson's disease	0.00207	0.00262	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—RPL6—Parkinson's disease	0.00199	0.00251	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—RPL6—Parkinson's disease	0.00199	0.00251	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—GSTA4—Parkinson's disease	0.00187	0.00237	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00185	0.00233	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	0.0018	0.00228	CbGpPWpGaD
Tazarotene—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.00176	0.00222	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—RPL23A—Parkinson's disease	0.00175	0.00221	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—RPL14—Parkinson's disease	0.00175	0.00221	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	0.00173	0.00219	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—TNF—Parkinson's disease	0.00171	0.00216	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—MAOB—Parkinson's disease	0.00167	0.00211	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	0.00166	0.0021	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—RPS8—Parkinson's disease	0.00163	0.00206	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	0.00159	0.00201	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—RPL23A—Parkinson's disease	0.00157	0.00198	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—RPL14—Parkinson's disease	0.00157	0.00198	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—RPL23A—Parkinson's disease	0.00151	0.0019	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—RPL14—Parkinson's disease	0.00151	0.0019	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—RPL23A—Parkinson's disease	0.00151	0.0019	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—RPL14—Parkinson's disease	0.00151	0.0019	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—RPS8—Parkinson's disease	0.00146	0.00185	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—RPS8—Parkinson's disease	0.0014	0.00177	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—RPS8—Parkinson's disease	0.0014	0.00177	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—IL6—Parkinson's disease	0.00138	0.00175	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	0.00131	0.00166	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—HSPA8—Parkinson's disease	0.00131	0.00165	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—CTGF—Parkinson's disease	0.0013	0.00165	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	0.00126	0.00159	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—CYP2D6—Parkinson's disease	0.00124	0.00157	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.00122	0.00155	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—HSPA1A—Parkinson's disease	0.00119	0.00151	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—HSPA8—Parkinson's disease	0.00117	0.00148	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—CTGF—Parkinson's disease	0.00117	0.00148	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—CYP2E1—Parkinson's disease	0.00113	0.00143	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—HSPA8—Parkinson's disease	0.00112	0.00142	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—HSPA8—Parkinson's disease	0.00112	0.00142	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—CTGF—Parkinson's disease	0.00112	0.00142	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—CTGF—Parkinson's disease	0.00112	0.00142	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.00112	0.00141	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—HSPA1A—Parkinson's disease	0.00107	0.00135	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.00104	0.00131	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—HSPA1A—Parkinson's disease	0.00102	0.00129	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—HSPA1A—Parkinson's disease	0.00102	0.00129	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—COMT—Parkinson's disease	0.00094	0.00119	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—GSTP1—Parkinson's disease	0.000935	0.00118	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—MAOA—Parkinson's disease	0.000933	0.00118	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—COMT—Parkinson's disease	0.000927	0.00117	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000922	0.00117	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—GSTM1—Parkinson's disease	0.000859	0.00109	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000848	0.00107	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000647	0.000818	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ND3—Parkinson's disease	0.000609	0.00077	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—MCCC1—Parkinson's disease	0.000609	0.00077	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—OMD—Parkinson's disease	0.000573	0.000724	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—TALDO1—Parkinson's disease	0.000573	0.000724	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—NDUFB11—Parkinson's disease	0.000543	0.000686	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GCH1—Parkinson's disease	0.000518	0.000655	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000467	0.000591	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GBA—Parkinson's disease	0.000462	0.000584	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—FBP1—Parkinson's disease	0.000462	0.000584	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—DBH—Parkinson's disease	0.000462	0.000584	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—DDC—Parkinson's disease	0.000339	0.000428	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GSTA4—Parkinson's disease	0.00032	0.000405	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000316	0.000399	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PLA2G6—Parkinson's disease	0.000288	0.000364	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—MAOB—Parkinson's disease	0.000285	0.000361	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000272	0.000343	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CYP2D6—Parkinson's disease	0.000212	0.000268	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CTGF—Parkinson's disease	0.000208	0.000263	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CYP2E1—Parkinson's disease	0.000194	0.000245	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—NQO1—Parkinson's disease	0.000192	0.000242	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—TH—Parkinson's disease	0.000189	0.000239	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CYCS—Parkinson's disease	0.000181	0.000229	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—COMT—Parkinson's disease	0.000161	0.000203	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GSTP1—Parkinson's disease	0.00016	0.000202	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—MAOA—Parkinson's disease	0.00016	0.000202	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—HMOX1—Parkinson's disease	0.000158	0.000199	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ABCB1—Parkinson's disease	0.000151	0.000191	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GSTM1—Parkinson's disease	0.000147	0.000186	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GPX1—Parkinson's disease	0.000141	0.000178	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—MTHFR—Parkinson's disease	0.00013	0.000164	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—APOE—Parkinson's disease	0.000121	0.000153	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—INS—Parkinson's disease	0.000103	0.000131	CbGpPWpGaD
